Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers

Inclusion Criteria: * Age 18 years and older * Diagnosis of gastrointestinal cancers: esophageal, gastric, hepatocellular carcinoma, cholangiocarcinoma, pancreatic, neuroendocrine, small intestine, colorectal and anal cancers. * Patients can have early stage or advanced cancer and will be starting treatment with new, standard of care infusion therapy regimen at UCSF. * Ability to understand study procedures and to comply with them for the entire length of the study. * No limit on prior lines of therapy. * Access to smartphone, tablet, or computer with capability to use symptom tracking web site (must have mobile phone number or email address). * Willing and able to provide written, signed informed consent in English. * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: * Patients who have already started therapy prior to study enrollment. * Patients who are receiving their treatment outside of UCSF. * Participation in another clinical trial (therapeutic or non-therapeutic). * Patients who are on therapy with oral oncolytics or combination therapy of oral oncolytics and infusional agents. * Patients who are non-English speakers.